|
Volumn 121, Issue , 1996, Pages 997-998
|
Pflicht zur Aufklärung über Unverträglichkeitsrisiken bei der Gabe von Medikamenten
a
a
NONE
(Germany)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
ANTIDEPRESSANT AGENT;
NEUROLEPTIC AGENT;
PIPAMPERONE;
DRUG;
ANXIETY;
CLINICAL PRACTICE;
DEPRESSION;
DRUG INDICATION;
HUMAN;
SHORT SURVEY;
ARTICLE;
DOCTOR PATIENT RELATION;
DRUG TOLERANCE;
FALLING;
FEMALE;
GERMANY;
HEAD INJURY;
LEGAL ASPECT;
MIDDLE AGED;
PATIENT EDUCATION;
RISK FACTOR;
ACCIDENTAL FALLS;
CRANIOCEREBRAL TRAUMA;
DRUG TOLERANCE;
FEMALE;
GERMANY;
HUMANS;
MIDDLE AGED;
PATIENT EDUCATION;
PHARMACEUTICAL PREPARATIONS;
PHYSICIAN-PATIENT RELATIONS;
RISK FACTORS;
|
EID: 0029957051
PISSN: 00120472
EISSN: 14394413
Source Type: Journal
DOI: 10.1055/s-0029-1233821 Document Type: Article |
Times cited : (1)
|
References (0)
|